Senhance robotic radical prostatectomy: A single-centre, 3-year experience

Area of Science:

• Robotic Surgery
• Urologic Oncology
• Surgical Innovation

Background:

• Senhance Surgical System, a novel robotic platform, has been utilized at University Hospital Centre Zagreb since February 2019.
• This study details the initial 3-year clinical experience with the Senhance platform.

Purpose of the Study:

• To evaluate the feasibility and safety of robotic radical prostatectomy (RRP) using the Senhance Surgical System.
• To report on the initial outcomes and complications associated with this robotic platform.

Main Methods:

• Prospective data collection from 200 patients undergoing extraperitoneal RRP between May 2019 and March 2022.
• Analysis of patient demographics, surgical outcomes, complication rates, and functional results.

Main Results:

• The median patient age was 65 years, with a median PSA of 6.9 ng/mL; most patients had T1c stage disease.
• Estimated blood loss averaged 250 mL, with 8 conversions to open or laparoscopic procedures.
• 15 early postoperative complications were recorded (11 Clavien-Dindo grade I, 3 grade II, 1 grade IV).
• Among the first 150 patients, 93.3% demonstrated good urinary control.

Conclusions:

• Robotic radical prostatectomy performed with the Senhance system is a feasible and safe surgical option.
• The procedure demonstrates promising initial functional and oncological outcomes.